Panagora Asset Management’s 2seventy bio TSVT Stock Holding History

Panagora Asset Management’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22,741	Closed	-$112K	–	1217
2025 Q1	$112K	Buy	+22,741	New	+$72.2K	﹤0.01%	1074
2024 Q1	–	Sell	-212,982	Closed	-$909K	–	1259
2023 Q4	$909K	Sell	212,982 -4,248	-2%	-$13.1K	0.01%	843
2023 Q3	$852K	Buy	+217,230	New	+$1.42M	0.01%	828

Other funds holding TSVT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Panagora Asset Management's TSVT Position: Q2 2025 in Review

Panagora Asset Management sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 22,741 shares — an estimated $112K sold.

Panagora Asset Management first reported a position in TSVT in Q3 2023 and held it in 3 quarters. The position peaked at $909K in Q4 2023. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

Panagora Asset Management reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
Panagora Asset Management sold 22,741 2seventy bio shares in Q2 2025, an estimated $112K.
Panagora Asset Management first reported a position in 2seventy bio in Q3 2023 and held it in 3 quarters.
Panagora Asset Management's 2seventy bio position peaked at $909K in Q4 2023.
2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Panagora Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.